George A. Bray, MD
There is clear and convincing evidence that modern appetite-suppressant drugs are effective and safe. However, there are several barriers to the proper use of these drugs and other treatments. These barriers include the public perception that obesity is a disease resulting from a lack of willpower, the professional expectation that appetite-suppressant drugs should cure obesity, hindrance by state licensing agencies, regulatory rigidity, limited research funding, and legislative grandstanding.
Clinical and experimental data suggest that modern appetite-suppressant drugs have little risk (1, 2). Drug abuse with amphetamine, methamphetamine, and phenmetrazine is well recognized, and these drugs have no place in the
Learn more about subscription options.
Register Now for a free account.
Bray GA. Barriers to the Treatment of Obesity. Ann Intern Med. 1991;115:152–153. doi: 10.7326/0003-4819-115-2-152
Download citation file:
Published: Ann Intern Med. 1991;115(2):152-153.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only